(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.29%) $79.22
(-0.23%) $2.18
(-0.27%) $2 316.10
(-0.13%) $27.57
(0.02%) $984.80
(0.09%) $0.930
(0.06%) $10.91
(0.11%) $0.800
(0.33%) $91.75
Quarter results tomorrow
(bmo 2024-05-09)
Expected move: +/- 10.78%
-3.26% $ 0.800
@ $0.697
Emitido: 14 feb 2024 @ 09:37
Retorno: 14.74%
Señal anterior: feb 12 - 14:32
Señal anterior:
Retorno: 4.84 %
Live Chart Being Loaded With Signals
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform...
Stats | |
---|---|
Volumen de hoy | 504 536 |
Volumen promedio | 806 311 |
Capitalización de mercado | 77.24M |
EPS | $0 ( 2024-03-20 ) |
Próxima fecha de ganancias | ( $-0.120 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.930 |
ATR14 | $0.00400 (0.50%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Orlinger Klaus | Buy | 367 300 | Stock Option (Right to Buy) |
2024-04-15 | Aldag Jorn | Buy | 971 400 | Stock Option (Right to Buy) |
2024-04-15 | Winderlich Mark | Buy | 250 000 | Stock Option (Right to Buy) |
2024-04-15 | Winderlich Mark | Buy | 50 000 | Stock Option (Right to Buy) |
2024-04-15 | Kandera Reinhard | Buy | 406 200 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
98.82 |
Last 94 transactions |
Buy: 7 455 375 | Sell: 565 370 |
Volumen Correlación
HOOKIPA Pharma Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
TCRT | 0.916 |
VSTA | 0.914 |
JNCE | 0.904 |
INFI | 0.903 |
MPAA | 0.903 |
VCSA | 0.902 |
POWW | 0.899 |
VIRX | 0.899 |
GRAY | 0.897 |
TOI | 0.896 |
10 Correlaciones Más Negativas | |
---|---|
IMMR | -0.897 |
PBFS | -0.892 |
BNIXU | -0.887 |
ISIG | -0.875 |
WEN | -0.873 |
CCRC | -0.872 |
MGI | -0.869 |
SEDG | -0.864 |
IBEX | -0.862 |
MSON | -0.859 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
HOOKIPA Pharma Inc Correlación - Moneda/Commodity
HOOKIPA Pharma Inc Finanzas
Annual | 2023 |
Ingresos: | $20.13M |
Beneficio Bruto: | $16.58M (82.35 %) |
EPS: | $-0.860 |
FY | 2023 |
Ingresos: | $20.13M |
Beneficio Bruto: | $16.58M (82.35 %) |
EPS: | $-0.860 |
FY | 2022 |
Ingresos: | $14.25M |
Beneficio Bruto: | $10.65M (74.72 %) |
EPS: | $-0.990 |
FY | 2021 |
Ingresos: | $18.45M |
Beneficio Bruto: | $18.45M (100.00 %) |
EPS: | $-2.79 |
Financial Reports:
No articles found.
HOOKIPA Pharma Inc
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico